Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Wellnex Life.
RELATED STOCKHEAD STORIES
Health & Biotech
Wellnex directors commit to $1.5 million in entitlement offer ahead of London listing
News
Closing Bell: ASX sinks as soft earnings melt hopes; Fortescue and Magellan hit hard
Health & Biotech
London calling: Wellnex Life secures $14.3 million for LSE listing
Health & Biotech
Wellnex Life secures $9m to propel dual listing on London’s AIM market
Health & Biotech
Vital Signs Podcast: Wellnex Life takes on London
Health & Biotech
Biocurious: Consumer health minnow Wellnex Life gears up for company-making Eurotrip
Health & Biotech
Wellnex Secures TGA approval for Liquid Paracetamol plus Caffeine Soft Gel as it targets growth opportunities
Health & Biotech
Wellnex ready for dual UK listing in new year after record November sales
Health & Biotech
Health Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slump
News
Closing Bell: Telix, banks lift ASX; but Newmont and Fortescue trip over soaring costs
Health & Biotech
Health Check: It’s all in the vibe as Invion and Wellness Life shrink to share greatness
Experts
FREE WHELAN: ‘The time has come’
News
Closing Bell: ASX axed in regional rout while mini-biotech Tissue Repair soars on TGA nod
Experts
FREE WHELAN: Own copper. Own copper companies. Hold on as long as you can
Health & Biotech
Weed Week: Getting a grip on the cannabis scene amid a pending regulatory shakeup
Health & Biotech
ASX wellness stocks offering calm and anxiety relief – Part 2
Experts
